Skip to Content

New Drug Approvals Archive - October 2002

October 2002

Pegasys (peginterferon alfa-2a) Injection

Date of Approval: October 16, 2002
Company: Hoffmann-La Roche
Treatment for: Chronic Hepatitis C

Pegasys (peginterferon alfa-2a) is a covalent conjugate of recombinant alfa-2a interferon indicated for the combination treatment of adults with chronic hepatitis C.

New Drug Approvals Archive